相关实验视频

Updated: Jun 20, 2025

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

免疫调节器衍生的纳米粒子诱导神经保护和调节性T细胞作用,以缓解帕金森症

Mohammed Nadim Sardoiwala¹, Liku Biswal¹, Subhasree Roy Choudhury¹

¹Epigenetics Research Laboratory, Institute of Nano Science and Technology, Knowledge City, Sector 81, Mohali, Punjab 140306, India.

ACS applied materials & interfaces

|July 17, 2024

概括

这项研究开发了FTY720纳米颗粒来治疗帕金森病 (PD). 该纳米配方通过表观遗传调节利用调节性T (Treg) 细胞活性,在PD模型中显示出显著的神经保护.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
纳米技术纳米技术

背景情况:

帕金森病 (PD) 的发病包括神经炎症和α-synuclein聚合.
神经免疫相互作用,特别是T细胞活性,在PD中至关重要.
调节性T (Treg) 细胞在PD治疗中显示出治疗潜力.

研究的目的:

探索FTY720纳米粒子在PD实验模型中的神经保护作用.
研究FTY720涉及蛋白酸酶2A (PP2A) 和表观遗传调节的机制.
通过增强Treg细胞功能来评估FTY720纳米颗粒在PD治疗中的潜力.

主要方法:

合成和FTY720纳米粒子 (FTY720NP) 的确认.
在体内实验性PD模型中对FTY720NP的评估.
对行为变化和蛋白质表达的分析.
对PP2A/EZH2/FOXP3信号通路的研究.

主要成果:

在行为和蛋白质表达研究中,FTY720NPs表现出显著的神经保护效率.
证据证实FTY720NP会诱导PP2A/EZH2/FOXP3信号传递.
这种信号通路促进了用于PD治疗的Treg细胞诱导.

结论:

FTY720纳米颗粒显示出缓解PD的希望.
该纳米配方利用PP2A诱导的表观遗传调节进行神经免疫调节.
这种方法为临床PD治疗提供了一个新的策略.

关键词:

在 EZH2 中使用.这是FOXP3P3的.FTY72020的时间.在PP2A中,PP2A是PP2A.帕金森症帕金森症

更多相关视频

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Published on: April 15, 2014

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.